Inhibitory Effects of Statins on Cytomegalovirus Production in Human Cells: Comprehensive Analysis of Gene Expression Profiles

Journal of Experimental and Clinical Medicine

Volumn 3, Issue 1, 2011, Pages 40-45

  Murayama, Tsugiya ^a   Bi, Changxiao ^a   Li, Ying ^a   Ishigaki, Yasuhito ^b   Takano, Fumihide ^c   Takegami, Tsutomu ^b   Ohta, Tomihisa ^c   Sumino, Hiroyuki ^d   Ubukata, Kimiko ^e   Takahashi, Takashi ^e  

^a HOKURIKU UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d GUNMA UNIVERSITY HOSPITAL   (Japan)

^e KITASATO UNIVERSITY   (Japan)

Author keywords

DNA microarray; Human cytomegalovirus; Human embryonic lung; Statins; Viral replication

Indexed keywords

COMPACTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN 1; LATE PROTEIN; MESSENGER RNA; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN; CELL STRAIN HEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA MICROARRAY; DOWN REGULATION; DRUG MECHANISM; FIBROBLAST; GENE; GENE CDK2; GENE EXPRESSION PROFILING; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; PROGENY; PROTEIN EXPRESSION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN;

EID: 79951721465     PISSN: 18783317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jecm.2010.12.009     Document Type: Article

References (25)

1. Sissons J.G., Carmichael A.J. Clinical aspects and management of cytomegalovirus infection. J Infect 2002, 44:78-83.
2. Freitas V.R., Fraser-Smith E.B., Matthews T.R. Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo. Antiviral Res 1989, 12:205-212.
3. Murayama T., Yamaguchi N., Matsuno H., Eizuru Y. In vitro anti-cytomegalovirus activity of Kampo (Japanese herbal) medicine. Evid Based Complement Altern Med 2004, 1:285-289.
4. Suzuki J., Koga N., Kosuge H., Ogawa M., Haraguchi G., Maejima Y., Saiki H., et al. Pitavastatin suppresses acute and chronic rejection in murine cardiac allografts. Transplantation 2007, 83:1093-1097.
5. Nie C., Yang D., Liu G., Dong D., Ma Z., Fu H., Zhao Z., et al. Statins induce immunosuppressive effect on heterotopic limb allografts in rat through inhibiting T cell activation and proliferation. Eur J Pharmacol 2009, 602:168-175.
6. Potena L., Frascaroli G., Grigioni F., Lazzarotto T., Magnani G., Tomasi L., Coccolo F., et al. Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. Circulation 2004, 109:532-536.
7. Furukawa T., Fioretti A., Plotkin S. Growth characteristics of cytomegalovirus in human fibroblasts with demonstration of protein synthesis early in viral replication. J Virol 1973, 11:991-997.
8. Wentworth B.B., French L. Plaque assay of cytomegalovirus strain of human origin. Proc Soc Exp Biol Med 1970, 135:253-258.
9. Jacobs J.P., Jones C.M., Baille J.P. Characteristics of a diploid cell designated MRC-5. Nature 1970, 227:168-173.
10. Nishiwaki M., Fujimuro M., Teishikata Y., Inoue H., Sasajima H., Nakaso K., Nakashima K., et al. Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpes virus infections in peripheral blood leukocytes revealed by a multiplex PCR assay. J Med Virol 2006, 78:1635-1642.
11. Yamakawa J., Ishigaki Y., Takano F., Takahashi T., Yoshida J., Moriya J., Takata T., et al. The Kampo medicines Orengedokuto, Bofutsushosan and Boiogito have different activities to regulate gene expressions in differentiated rat white adipocytes: comprehensive analysis of genetic profiles. Biol Pharm Bull 2008, 31:2083-2089.
12. Furukawa Y., Iwase S., Terui Y., Kikuchi J., Sakai T., Nakamura M., Kitagawa S., et al. Transcriptional activation of the cdc2 gene is associated with Fas-induced apoptosis of human hematopoietic cells. J Biol Chem 1996, 271:28469-28477.
13. Boulay P.L., Cotton M., Melançon P., Claing A. ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells. J Biol Chem 2008, 283:36425-36434.
14. Mohindra A., Hays L.E., Phillips E.N., Preston B.D., Helleday T., Meuth M. Defects in homologous recombination repair in mismatch-repair-deficient tumour cell lines. Hum Mol Genet 2002, 11:2189-2200.
15. Wang J., Shiels C., Sasieni P., Wu P.J., Islam S.A., Freemont P.S., Sheer D. Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J Cell Biol 2004, 164:515-526.
16. Wong W.W., Dimitroulakos J., Minden M.D., Penn L.Z. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 2002, 16:508-519.
17. Hackam D.G., Mamdani M., Li P., Redelmeier D.A. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet 2006, 367:413-418.
18. Liu S., Rodriguez A.V., Tosteson M.T. Role of simvastatin and methyl-beta-cyclodextrin on inhibition of poliovirus infection. Biochem Biophys Res Commun 2006, 347:51-59.
19. del Real G., Jiménez-Baranda S., Mira E., Lacalle R.A., Lucas P., Gómez-Moutón C., Alegret M., et al. Statins inhibit HIV-1 infection by down-regulating Rho activity. J Exp Med 2004, 200:541-547.
20. Bader T., Fazili J., Madhoun M., Aston C., Hughes D., Rizvi S., Seres K., et al. Fluvastatin inhibits hepatitis C replication in humans. Am J Gastroenterol 2008, 103:1383-1389.
21. Liu Z., Guo Z., Wang G., Zhang D., He H., Li G., Liu Y., et al. Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice. Eur J Pharm Sci 2009, 38:215-223.
22. Ukomadu C., Dutta A. Inhibition of cdk2 activating phosphorylation by mevastatin. J Biol Chem 2003, 278:4840-4846.
23. Bresnahan W.A., Boldogh I., Chi P., Thompson E.A., Albrecht T. Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 1997, 231:239-247.
24. Thaker N.G., Zhang F., McDonald P.R., Shun T.Y., Lewen M.D., Pollack I.F., Lazo J.S. Identification of survival genes in human glioblastoma cells by small interfering RNA screening. Mol Pharmacol 2009, 76:1246-1255.
25. Caddle L.B., Hasham M.G., Schott W.H., Shirley B.J., Mills K.D. Homologous recombination is necessary for normal lymphocyte development. Mol Cell Biol 2008, 28:2295-2303.